Hassell Anne M, An Gang, Bledsoe Randy K, Bynum Jane M, Carter H Luke, Deng Su-Jun J, Gampe Robert T, Grisard Tamara E, Madauss Kevin P, Nolte Robert T, Rocque Warren J, Wang Liping, Weaver Kurt L, Williams Shawn P, Wisely G Bruce, Xu Robert, Shewchuk Lisa M
Department of Computational, Analytical and Structural Sciences, Glaxo SmithKline, 5 Moore Drive, Research Triangle Park, NC 27709, USA.
Acta Crystallogr D Biol Crystallogr. 2007 Jan;63(Pt 1):72-9. doi: 10.1107/S0907444906047020. Epub 2006 Dec 13.
Obtaining diffraction-quality crystals has long been a bottleneck in solving the three-dimensional structures of proteins. Often proteins may be stabilized when they are complexed with a substrate, nucleic acid, cofactor or small molecule. These ligands, on the other hand, have the potential to induce significant conformational changes to the protein and ab initio screening may be required to find a new crystal form. This paper presents an overview of strategies in the following areas for obtaining crystals of protein-ligand complexes: (i) co-expression of the protein with the ligands of interest, (ii) use of the ligands during protein purification, (iii) cocrystallization and (iv) soaks.
长期以来,获得衍射质量的晶体一直是解析蛋白质三维结构的瓶颈。蛋白质与底物、核酸、辅因子或小分子结合时通常会得到稳定。另一方面,这些配体有可能诱导蛋白质发生显著的构象变化,可能需要从头筛选以找到新的晶体形式。本文概述了在以下几个方面获得蛋白质-配体复合物晶体的策略:(i) 蛋白质与感兴趣的配体共表达,(ii) 在蛋白质纯化过程中使用配体,(iii) 共结晶和 (iv) 浸泡。
Acta Crystallogr D Biol Crystallogr. 2007-1
Acta Crystallogr D Biol Crystallogr. 2006-6
Methods Mol Biol. 2005
Acta Crystallogr D Biol Crystallogr. 2011-9
Methods Mol Biol. 2009
Methods Mol Biol. 2025
Acta Crystallogr F Struct Biol Commun. 2025-3-1
Acta Crystallogr D Struct Biol. 2023-9-1
Acta Crystallogr D Biol Crystallogr. 2006-1
Nature. 1998-5-28
Proc Natl Acad Sci U S A. 1998-5-26
Nature. 1997-10-16